This specificity to the infrarenal abdominal aorta, coupled with significant elevations in cytokines like MCP-1, IL-6, IL-1β, and MMP2 and MMP9, facilitates detailed investigations into AAA progression and potential therapeutic interventions. The gene discussed is IL1B; the disease is triple-A syndrome.